Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer

NCT01492543 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Chinese Academy of Medical Sciences

Collaborators